seen from United States
seen from China
seen from United States
seen from United States
seen from Malaysia
seen from United States
seen from Japan
seen from Japan
seen from Australia
seen from Germany
seen from Malaysia
seen from United States
seen from United States
seen from Germany
seen from Ukraine
seen from Russia
seen from United States
seen from Germany
seen from China
seen from Armenia
Zidebactam
Zidebactam FDA 2026, APPROVALS 2026 To treat complicated urinary tract infections, including pyelonephritis, caused by designated susceptible microorganisms CAS 1436861-97-0, UNII: YPM97423DB, Wockhardt Biopharm, WCK-5107, WCK5107 Molecular Formula, C13-H21-N5-O7-S Molecular Weight, 391.4029 Disclosed in PCT International Patent Application No. PCT/IB2012/054290D 01 Aug 2015 Phase-I…
View On WordPress
WCK 5107 in PHASE 1 FROM WOCKHARDT
WCK 5107 in PHASE 1 FROM WOCKHARDT
WCK 5107 Wockhardt Limited Useful for treating bacterial infections CAS 1436861-97-0 disclosed in PCT International Patent Application No. PCT/IB2012/054290D trans- sulphuric acid mono-[2-(N’-[(R)-piperidin-3-carbonyl]-hydrazinocarbonyl)-7-oxo-l,6-diaza-bicyclo[3.2.1]oct-6-yl] ester (2S, 5R)-sulphuric acid…
View On WordPress
